文献速递治疗药物监测与药物基因组学药物相互作用

氟氯西林迅速降低丙戊酸血清水平:一例病例报告

Flucloxacillin instantly decreases serum levels of valproic acid: A case report.
PubMed 文献 · Br J Clin Pharmacol · 2024-09-10

一例79岁男性双相障碍患者在接受丙戊酸治疗期间,因金黄色葡萄球菌菌血症加用氟氯西林后,丙戊酸总血清水平急剧下降75%。游离 fraction 血清水平仍维持在治疗范围(5-25 mg/L),双相障碍病情稳定,无需调整剂量。提示氟氯西林可能通过诱导葡萄糖醛酸转移酶加速丙戊酸代谢,建议双相障碍患者监测游离丙戊酸水平,癫痫患者考虑替代抗生素。

要点

  • 氟氯西林可使丙戊酸总血清水平下降75%,为首次报道的药物相互作用。
  • 游离丙戊酸水平维持在5-25 mg/L治疗范围内,双相障碍症状稳定。
  • 双相障碍患者合用氟氯西林时应监测游离丙戊酸水平,癫痫患者建议换用其他抗生素。

核心结论

  • 氟氯西林可迅速降低丙戊酸总血清水平达75%,但游离 fraction 水平仍保持治疗范围,双相障碍患者病情稳定。

研究设计与样本

  • 单例病例报告:79岁男性双相障碍患者,因金黄色葡萄球菌菌血症加用氟氯西林,观察丙戊酸血清水平变化。

主要发现

  • 氟氯西林治疗期间丙戊酸总血清水平下降75%,排除依从性和吸收问题后确认其作用。
  • 游离 fraction 丙戊酸血清水平维持在5-25 mg/L治疗范围内,患者双相障碍稳定于1000 mg每日两次剂量。
  • 机制推测为氟氯西林通过孕烷X受体通路诱导葡萄糖醛酸转移酶,加速丙戊酸代谢,而非细胞色素P450诱导。

关键数值与推荐

  • 丙戊酸游离 fraction 血清水平治疗范围为5-25 mg/L。
  • 患者双相障碍稳定时丙戊酸剂量为1000 mg每日两次。

临床怎么用

  • 双相障碍患者使用丙戊酸联合氟氯西林时,应监测游离丙戊酸血清水平而非仅总水平。
  • 癫痫患者使用丙戊酸时,建议考虑替代抗生素以避免与氟氯西林的相互作用。

局限性

  • 单例病例报告,不能确立因果关系或推广至所有患者。
  • 机制推测基于既往报道,未在本例中直接验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Valproic acid (VPA) is used for epilepsy and bipolar disorder. It has near-complete bioavailability and is primarily metabolized by glucuronosyltransferases and mitochondrial oxidation. This case highlights a 79-year-old male with bipolar disorder on VPA therapy that started with flucloxacillin for Staphylococcus aureus bacteraemia and exhibited significantly reduced VPA serum levels. During hospitalization, flucloxacillin treatment correlated with a sharp decline of 75% in VPA total serum levels, a novel drug-drug interaction not previously reported. Nonadherence and absorption issues of VPA were ruled out, confirming flucloxacillin's role in reducing VPA levels. Because free-fraction serum levels of VPA remained within therapeutic range (5-25 mg/L) and our patient's bipolar disorder remained stable at 1000 mg twice daily, a dose increase was not necessary. Previous reports described cytochrome P450 enzyme induction as the mechanism of flucloxacillin lowering serum levels of immunosuppressants and antimycotics. Because only 10% of VPA is metabolized by cytochrome P450 enzymes, this is not plausible for this case. The proposed mechanism for the VPA-flucloxacillin drug-drug interaction is flucloxacillin as inducer of glucuronosyltransferase enzymes via the pregnane X receptor pathway, accelerating VPA metabolism. Because this case showed that free-fraction serum levels remained within therapeutic range, it underscores the need for free-fraction VPA monitoring in bipolar disorder and flucloxacillin therapy. When VPA is used for epilepsy, it is advised to consider alternative antibiotics to avoid this interaction.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. van der Meer DH, Elting LJ, van Egmond PS, et al. Flucloxacillin instantly decreases serum levels of valproic acid: A case report. Br J Clin Pharmacol. 2024. PMID: 39254135. doi:10.1111/bcp.16244

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。